New polycyclic tetramate macrolactams with antimycobacterial activity produced by marine-derived Streptomyces sp. KKMA-0239

Satoru Shigeno,Miyu Kadowaki,Kenichiro Nagai,Kanji Hosoda,Takeshi Terahara,Tomoyasu Nishimura,Naoki Hasegawa,Hiroshi Tomoda,Taichi Ohshiro
DOI: https://doi.org/10.1038/s41429-024-00710-w
2024-03-27
The Journal of Antibiotics
Abstract:During our screening for anti-mycobacterial agents against Mycobacterium avium complex (MAC), two new polycyclic tetramate macrolactams (PTMs), named hydroxycapsimycin ( 1 ) and brokamycin ( 2 ), were isolated along with the known PTM, ikarugamycin ( 3 ), from the culture broth of marine-derived Streptomyces sp. KKMA-0239. The relative structures of 1 and 2 were elucidated by spectroscopic data analyses, including 1D and 2D NMR. Furthermore, the absolute configuration of 1 was confirmed by a single-crystal X-ray diffraction analysis. Compounds 2 and 3 exhibited moderate antimycobacterial activities against MAC, including clinically isolated drug-resistant M. avium .
pharmacology & pharmacy,immunology,biotechnology & applied microbiology,microbiology
What problem does this paper attempt to address?